Celldex Therapeutics Inc CLDXNasdaq
42.97USDClose on 08/10
At a glance
Celldex Therapeutics Inc sits in the ‘Resting’ stage of its cycle. It has moved +390.5% since its first surge signal on 2020-06-11, when the past-year gain stood at +260.5%.
- Since surge signal
- +390.5%
- First surge signal
- 2020-06-11
- Price at signal
- 8.76
- Past-year gain (at signal)
- +260.5%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.